Company intelligence
Keros Therapeutics
Keros is dedicated to the discovery and development of novel therapeutics for multiple disorders.
Biotechnology Research
Lexington, US
122 employees
Founded 2016
2 public signals
About Keros Therapeutics
At Keros, our mission is to innovate therapies that have the potential to shift the treatment paradigm for a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins.
Verified activity
Signals from Keros Therapeutics
2 published signals
Presence & Recognition
Keros Therapeutics participated in World Duchenne Awareness Day to stand with the Duchenne muscular dystrophy community.
Reported by Keros Therapeutics
Legal & Regulatory
Keros Therapeutics received approval for rusfertide for polycythemia vera from Protagonist Therapeutics and Takeda.
Reported by Bob Gay